Diadema Partners’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-100,660
Closed -$616K 190
2026
Q1
$770K Sell
100,660
-130,337
-56% -$996K 0.13% 93
2025
Q4
$2.25M Buy
+230,997
New +$1.96M 0.39% 59
2025
Q3
Sell
-32,483
Closed -$208K 158
2025
Q2
$302K Sell
32,483
-42,047
-56% -$367K 0.09% 85
2025
Q1
$727K Sell
74,530
-39,470
-35% -$488K 0.19% 71
2024
Q4
$1.38M Buy
+114,000
New +$1.39M 0.59% 44

Other funds holding REPL

Diadema Partners's REPL Position: Q2 2026 in Review

Diadema Partners sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 100,660 shares — an estimated $616K sold.

Diadema Partners first reported a position in REPL in Q4 2024 and held it in 5 quarters. The position peaked at $2.25M in Q4 2025. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Diadema Partners reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
  • Diadema Partners sold 100,660 Replimune Group shares in Q2 2026, an estimated $616K.
  • Diadema Partners first reported a position in Replimune Group in Q4 2024 and held it in 5 quarters.
  • Diadema Partners's Replimune Group position peaked at $2.25M in Q4 2025.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Diadema Partners's 13F filing for Q2 2026, filed 14 Aug 2026.